Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera
Go back to Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera| Isilon Systems, Inc. (NASDAQ: SLN) | Delayed: 15.43 +3.48 (29.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.95 | 52 Week High | $0.27 | |||
| Open | $16.70 | 52 Week Low | $0.18 | |||
| Day High | $17.58 | P/E | N/A | |||
| Day Low | $14.62 | EPS | $-0.44 | |||
| Volume | 16,207,536 | |||||
